Cero Therapeutics Files 8-K
Ticker: CEROW · Form: 8-K · Filed: Jun 17, 2025 · CIK: 1870404
Sentiment: neutral
Topics: corporate-filing, 8-K, company-update
TL;DR
Cero Therapeutics filed an 8-K on 6/17/25. Routine update.
AI Summary
Cero Therapeutics Holdings, Inc. filed an 8-K on June 17, 2025, reporting other events and financial statements. The company, formerly known as Phoenix Biotech Acquisition Corp. until June 30, 2021, is incorporated in Delaware and operates in the biological products sector.
Why It Matters
This filing indicates routine corporate reporting and potential updates on financial status or significant events for Cero Therapeutics Holdings, Inc.
Risk Assessment
Risk Level: low — The filing appears to be a standard 8-K for reporting purposes, with no immediate indication of significant financial distress or major strategic shifts.
Key Players & Entities
- CERO THERAPEUTICS HOLDINGS, INC. (company) — Registrant
- June 17, 2025 (date) — Date of Report
- Phoenix Biotech Acquisition Corp. (company) — Former Company Name
- June 30, 2021 (date) — Date of Name Change
- Delaware (jurisdiction) — State of Incorporation
FAQ
What is the primary purpose of this 8-K filing for Cero Therapeutics Holdings, Inc.?
The 8-K filing on June 17, 2025, is for reporting 'Other Events' and 'Financial Statements and Exhibits'.
When did Cero Therapeutics Holdings, Inc. change its name?
The company's name was changed from Phoenix Biotech Acquisition Corp. on June 30, 2021.
In which state is Cero Therapeutics Holdings, Inc. incorporated?
Cero Therapeutics Holdings, Inc. is incorporated in Delaware.
What is the Standard Industrial Classification (SIC) code for Cero Therapeutics Holdings, Inc.?
The SIC code for Cero Therapeutics Holdings, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What is the business address of Cero Therapeutics Holdings, Inc.?
The business address is 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CA 94080.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 regarding CERO THERAPEUTICS HOLDINGS, INC. (CEROW).